Papers
Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data
BMJ 2005; 331 doi: https://doi.org/10.1136/bmj.38569.471007.AE (Published 06 October 2005) Cite this as: BMJ 2005;331:810
Related articles
- This Week In The BMJ Published: 06 October 2005; BMJ 331 doi:10.1136/bmj.331.7520.0-a
- Analysis Published: 01 November 2007; BMJ 335 doi:10.1136/bmj.39343.408449.80
- Editorial Published: 10 July 2003; BMJ 327 doi:10.1136/bmj.327.7406.65
- Paper Published: 13 September 1997; BMJ 315 doi:10.1136/bmj.315.7109.629
- Education And Debate Published: 04 September 2003; BMJ 327 doi:10.1136/bmj.327.7414.557
- Paper Published: 24 April 1999; BMJ 318 doi:10.1136/bmj.318.7191.1104
See more
- Constitutional symptoms in a young personBMJ December 07, 2016, 355 i5781; DOI: https://doi.org/10.1136/bmj.i5781
- Preserving fertility in girls and young women with cancerBMJ November 30, 2016, 355 i6145; DOI: https://doi.org/10.1136/bmj.i6145
- Hospital transmitted Candida auris infections confirmed in the USBMJ November 07, 2016, 355 i5978; DOI: https://doi.org/10.1136/bmj.i5978
- US transplant study may have violated federal rulesBMJ November 04, 2016, 355 i5956; DOI: https://doi.org/10.1136/bmj.i5956
- Patient threatens legal action over lack of compensation for hepatitis C contaminated bloodBMJ September 15, 2016, 354 i4937; DOI: https://doi.org/10.1136/bmj.i4937
Cited by...
- Risk and management of cardiac disease in kidney and liver transplant recipients
- New Onset Diabetes Mellitus after Transplant: The Challenge Continues
- Post-transplant diabetes mellitus
- Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study
- Understanding Trends in Kidney Function 1 Year after Kidney Transplant in the United States
- Impact of intrapatient variability (IPV) in tacrolimus trough levels on long-term renal transplant function: multicentre collaborative retrospective cohort study protocol
- Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival
- Choosing the right dose of tacrolimus
- De Novo Glomerular Diseases after Renal Transplantation
- Pancreatic {beta}-Cell Dysfunction and Risk of New-Onset Diabetes After Kidney Transplantation
- Current trends in immunosuppressive therapies for renal transplant recipients
- New-Onset Diabetes After Renal Transplantation: Risk assessment and management
- Meta-Analysis of Calcineurin-Inhibitor-Sparing Regimens in Kidney Transplantation
- Tacrolimus-Induced Neutropenia in Renal Transplant Recipients
- Daclizumab versus Antithymocyte Globulin in High-Immunological-Risk Renal Transplant Recipients
- Calcineurin Inhibitor Nephrotoxicity
- Need for Quality Improvement in Renal Systematic Reviews
- Management of Cardiovascular Disease in Renal Transplant Recipients
- Orthodontic treatment of a patient with a renal transplant and drug-induced gingival overgrowth: a case report
- Uncertainty in heterogeneity estimates in meta-analyses
- Therapeutic Monitoring of Calcineurin Inhibitors for the Nephrologist
- New-Onset Diabetes after Kidney Transplantation: Risk Factors
- Role of Maintenance Immunosuppressive Regimen in Kidney Transplant Outcome